Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back

Become EABM
Become Reviewer

Spectrum of Radiopharmaceuticals in Nuclear Oncology

Volume:6   Issue: 3
Pp: 181-196
Delphine Denoyer, Nathalie Perek, Nathalie L. Jeune and Francis Dubois
DOI: 10.2174/156800906776842984

γ-H2AX as a Therapeutic Target for Improving the Efficacy of Radiation Therapy

Volume:6   Issue: 3
Pp: 197-205
J. Kao, M. T. Milano, A. Javaheri, M. C. Garofalo, S. J. Chmura, R. R. Weichselbaum and S. J. Kron
DOI: 10.2174/156800906776842957

Molecular Targets of Ovarian Carcinomas with Acquired Resistance to Platinum/Taxane Chemotherapy

Volume:6   Issue: 3
Pp: 207-227
Christian Kurzeder, Georg Sauer and Helmut Deissler
DOI: 10.2174/156800906776842975

Vitamin D Receptor is a Novel Drug Target for Ovarian Cancer Treatment

Volume:6   Issue: 3
Pp: 229-244
Xiaohui Zhang, Santo V. Nicosia and Wenlong Bai
DOI: 10.2174/156800906776842939

Specialisation of the Tropomyosin Composition of Actin Filaments Provides New Potential Targets for Chemotherapy

Volume:6   Issue: 3
Pp: 245-256
Justine R. Stehn, Galina Schevzov, Geraldine M. O'Neill and Peter W. Gunning
DOI: 10.2174/156800906776842948

Gonadotropin-Releasing Hormone (GnRH) Receptors in Tumors: a New Rationale for the Therapeutical Application of GnRH Analogs in Cancer Patients?

Volume:6   Issue: 3
Pp: 257-269
M. M. Marelli, R. M. Moretti, J. Januszkiewicz-Caulier, M. Motta and P. Limonta
DOI: 10.2174/156800906776842966